PMC:7755033 / 78020-78205
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1265 | 25-33 | Chemical | denotes | losartan | MESH:D019808 |
| 1266 | 35-53 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
| 1267 | 58-68 | Chemical | denotes | poziotinib | MESH:C557213 |
| 1268 | 101-113 | Chemical | denotes | procainamide | MESH:D011342 |
| 1269 | 115-125 | Chemical | denotes | cinacalcet | MESH:D000069449 |
| 1270 | 127-134 | Chemical | denotes | arbidol | MESH:C086979 |
| 1271 | 139-149 | Chemical | denotes | oberadilol |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T770 | 0-185 | Sentence | denotes | Standard reference drugs losartan, hydroxychloroquine and poziotinib were found to be active whereas procainamide, cinacalcet, arbidol and oberadilol were found to be moderately active. |